Tannapfel, A <br/><br/>
[Molecular pathology analysis of the KRAS mutation status in patients with metastasized colorectal carcinoma: an initial approach using predictive pathology].  [electronic resource] 

 -  Der Pathologe  Feb 2008 
 - 93-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1963 
<br/><br/><label>Standard No.: </label>10.1007/s00292-007-0966-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--therapeutic use<br/>Bevacizumab<br/>Cetuximab<br/>Colorectal Neoplasms--drug therapy<br/>DNA Mutational Analysis<br/>ErbB Receptors--antagonists & inhibitors<br/>Genes, ras<br/>Humans<br/>Mutation<br/>Neovascularization, Pathologic--drug therapy<br/>Prognosis<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>ras Proteins--genetics